A platelet-rich plasma (PRP) protocol is any standardized sequence of steps used to draw a patient’s blood, concentrate its platelets, and deliver that concentrate back into injured or aging tissue. The process sounds simple, but nearly every variable along the way changes what ends up in the syringe: spin speed, spin count, anticoagulant choice, whether white blood cells stay in or get removed, and how (or whether) the platelets are activated before injection. Because no single PRP protocol has become the universal standard, two clinics offering “PRP therapy” may be delivering meaningfully different products, which partly explains why study results across the field can look contradictory.
How PRP Works at the Tissue Level
Platelets are best known for clotting, but they also carry tiny storage compartments called alpha granules packed with growth factors and signaling molecules. When platelets are activated, those granules release proteins that recruit repair cells, promote new blood vessel formation, and stimulate collagen production. The process is not a simple on-off switch. Platelets can release pro-growth signals like VEGF through one activation pathway while releasing vessel-inhibiting signals like endostatin through another, depending on which chemical trigger they encounter.1Blood. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis That selectivity is one reason the activation step in a PRP protocol matters so much.
Single Spin Versus Double Spin
The centrifuge step is the heart of any PRP protocol. A single spin separates whole blood into layers: red blood cells sink to the bottom, a thin “buffy coat” of white blood cells and platelets sits in the middle, and platelet-poor plasma rises to the top. A double-spin protocol takes the platelet-containing layer from the first spin and spins it again at a different speed, concentrating platelets further into a smaller volume.
A comparison of the two methods found that double-spin PRP yielded a platelet concentration roughly 75 percent higher than single-spin PRP.2PubMed Central. Comparison of single and double centrifugation methods for preparation of Platelet-Rich Plasma (PRP) That might seem like a clear win for double spin, but more is not always better. A clinical trial in people with hair loss found that both single- and double-spin preparations increased platelet counts by four to five times over baseline, with the single-spin group actually showing a more consistent increase. Both groups improved clinically in hair density measures.3PubMed Central. Comparing Single-spin Versus Double-spin Platelet-rich Plasma Centrifugation Methods on Thrombocyte Count and Clinical Improvement of Androgenetic Alopecia The double-spin method also tends to capture more white blood cells and red blood cells in the final product, which can be either an advantage or a drawback depending on the treatment target.
Why the Anticoagulant in the Collection Tube Matters
Blood drawn for PRP goes into a tube containing an anticoagulant to prevent clotting before processing. The most commonly used options are acid citrate dextrose (ACD-A), sodium citrate, EDTA, and heparin. They might seem like interchangeable plumbing, but they affect platelet behavior in subtle ways.
A comparative study found that EDTA and heparin caused platelets to swell and activated them prematurely, as measured by increased surface expression of the activation marker CD62P. Both also appeared to reduce the effectiveness of calcium chloride stimulation later in the process. ACD-A kept platelets closer to their resting state and preserved their ability to respond to activation signals.4PubMed Central. A Comparative Study of the Effects of Anticoagulants on Pure Platelet-Rich Plasma Quality and Potency An equine study, meanwhile, found that the choice between sodium citrate and ACD did not significantly affect final cell counts.5PubMed Central. Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel The practical takeaway is that ACD-A or sodium citrate are generally preferred for PRP because they interfere less with platelet function, while EDTA and heparin are better suited to routine blood counts in a diagnostic lab.
Leukocyte-Rich Versus Leukocyte-Poor Formulations
One of the biggest protocol decisions is whether to include white blood cells (leukocytes) in the final product. Leukocyte-rich PRP (LR-PRP) is typically harvested from the buffy coat and contains a significant population of neutrophils and monocytes alongside platelets. Leukocyte-poor PRP (LP-PRP) is drawn from the plasma layer above the buffy coat, excluding most white cells.
The debate around this choice has gone back and forth for years. Some researchers argue that white blood cells introduce inflammatory cytokines that could damage delicate tissue like joint cartilage. Others point out that monocytes in the buffy coat can shift from a pro-inflammatory state to a reparative state, potentially aiding healing.6PubMed Central. Leukocyte-rich PRP versus leukocyte-poor PRP – The role of monocyte/macrophage function in the healing cascade A systematic review examining this question for osteoarthritis concluded that current evidence is insufficient to determine whether adding leukocytes provides a clinical benefit, with most studies showing no significant differences in outcomes between the two formulations.7Regenerative Therapy. Leukocyte-rich versus leukocyte-poor platelet-rich plasma for Osteoarthritis: A systematic review
What does seem clear is that red blood cell contamination is the real villain. When synoviocytes (the cells lining a joint) were exposed to a red blood cell concentrate in a lab study, cell death jumped significantly, and inflammatory markers spiked while anti-inflammatory markers stayed at zero.8PubMed Central. The Effect of Platelet-Rich Plasma Formulations and Blood Products on Human Synoviocytes So for joint injections, a preparation that minimizes red cells is more clearly supported than one that simply removes white cells.
Activation Methods and Growth Factor Release
Some protocols inject PRP without any activation step, relying on the body’s own collagen and tissue factors to trigger the platelets once they are in place. Others deliberately activate PRP before injection using calcium chloride, thrombin, or a combination of both. The choice changes the timing and quantity of growth factor release.
A study comparing these methods found that thrombin and the calcium-thrombin combination produced the fastest clot formation and the highest early burst of platelet-derived growth factor (PDGF). Calcium chloride alone was slower to form a clot but ultimately released more PDGF over 24 hours than thrombin alone. Collagen type I, by contrast, produced the lowest overall growth factor release and did not form a visible clot at any time point.9PubMed Central. Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules For injectable PRP, the no-activation approach is popular because the liquid form is easier to deliver through a needle. When a scaffold or membrane is needed, as in surgical wound coverage, calcium-based activation that forms a gel or clot can be more practical.
An in-vitro review also found an interaction between leukocyte content and optimal platelet concentration: researchers using low-leukocyte PRP observed a substantially higher optimal platelet concentration for cell proliferation than those using high-leukocyte PRP, possibly because white cell breakdown products inhibit growth at high densities.10PubMed Central. The optimal platelet concentration in platelet-rich plasma for proliferation of human cells in vitro This is a good example of how protocol variables interact: the “right” platelet count depends partly on whether leukocytes are present.
The Classification Problem
With so many protocol variables, comparing one PRP study to another is a headache. Several classification systems have been proposed. One widely referenced framework divides products into four families based on fibrin structure and cell content: pure PRP, leukocyte-and-platelet-rich plasma, pure platelet-rich fibrin, and leukocyte-and-platelet-rich fibrin.11PubMed Central. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine Another system, known as PAW, classifies products by three components: absolute platelet number, activation method, and presence or absence of white cells.12Arthroscopy. Platelet-rich plasma: the PAW classification system
Despite these efforts, a review of PRP reporting in clinical trials found that most studies do not provide enough information for their protocols to be reproduced, and no consensus classification has been validated.13PubMed. Classification systems for platelet-rich plasma If you are evaluating PRP research or comparing clinics, asking what classification a product falls under and what platelet count the final preparation achieved can tell you more than just knowing “PRP” was used.
PRP for Joints and Tendons
Knee osteoarthritis is the most studied orthopedic application. A randomized trial comparing PRP injections to hyaluronic acid (HA) and corticosteroid injections for knee osteoarthritis found no differences between groups at three months, but PRP showed significantly better pain and function scores at six, nine, and twelve months.14PubMed. Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis A separate trial tested a combined approach, injecting PRP one week before an HA injection, and found the combination outperformed PRP alone in pain, stiffness, and balance measures.15PubMed Central. Efficacy of a Novel Intra-Articular Administration of Platelet-Rich Plasma One-Week Prior to Hyaluronic Acid versus Platelet-Rich Plasma Alone in Knee Osteoarthritis
For chronic tendon problems, PRP is often combined with a technique called needle tenotomy, where a needle is used under ultrasound guidance to break up scar tissue within the tendon. A study of this combined approach reported average functional improvement of 68 percent and pain reduction of 58 percent, with 83 percent of patients satisfied with the outcome.16PubMed. Treatment of chronic tendinopathy with ultrasound-guided needle tenotomy and platelet-rich plasma injection A systematic review of needle tenotomy noted a trend suggesting that adding blood products like PRP may further improve outcomes, though the evidence was not definitive.17PubMed. Tendon needling for treatment of tendinopathy: A systematic review
PRP in Dermatology and Hair Restoration
Outside orthopedics, skin rejuvenation and hair loss are the most visible PRP applications. For skin, PRP injections stimulate fibroblasts to produce new collagen and elastin. Studies have shown measurable improvements in wrinkles, skin firmness, brown spots, and dermal collagen density, with patient satisfaction scores averaging above 90 percent at six-month follow-up in one trial.18PubMed. Autologous pure platelet-rich plasma injections for facial skin rejuvenation Histologic evidence from biopsied skin showed PRP-treated areas had roughly twice the collagen density improvement of saline-treated control areas.19PubMed Central. Histologic Evidence of New Collagen Formulation Using Platelet Rich Plasma in Skin Rejuvenation
For hair loss, PRP can be delivered by direct injection into the scalp or applied topically after microneedling. A systematic review found that microneedling with a 1.5 to 2 mm needle depth is sufficient to deliver PRP into the skin layer containing hair follicles.20PubMed Central. Local Injection versus Topical Microneedling of Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review A common clinical protocol uses a dermaroller rolled horizontally, vertically, and diagonally until pinpoint bleeding appears, then applies PRP topically. Sessions are typically repeated every four weeks for a total of four to six treatments.21PubMed Central. Platelet-Rich Plasma with Microneedling in Androgenetic Alopecia
PRP for Diabetic Foot Ulcers
Chronic wounds that resist conventional treatment are another area where PRP has accumulated solid evidence. A meta-analysis of randomized controlled trials found that PRP significantly improved healing rates (about 42 percent higher than conventional therapy), shortened healing time by roughly three weeks, and reduced the rate of amputation without increasing adverse events.22PubMed Central. Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcer healing: a systematic review and meta-analysis of randomized controlled trials A separate trial found injected PRP effective in reducing wound size in 80 percent of patients, compared to 46 percent with conventional dressing alone.23PubMed Central. Effectiveness of Injected Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcer Disease A review of the broader literature on PRP for diabetic foot ulcers confirmed that PRP plus standard care consistently outperformed standard care alone in both wound closure percentage and healing speed.24PubMed. Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers
What to Do Before and After a PRP Injection
The protocol does not end when the needle comes out. How you prepare for and recover from a PRP injection can influence results, and this is one of the most inconsistently reported parts of the PRP literature.
A major concern is nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen. A study looking at naproxen’s effect on PRP found that just one week of use caused PDGF-AA levels to drop by about 44 percent and PDGF-AB levels by about 47 percent. After a one-week washout period off the drug, levels bounced back to baseline.25PubMed Central. The Influence of Naproxen on Biological Factors in Leukocyte-Rich Platelet-Rich Plasma This gives a practical rationale for the common instruction to stop NSAIDs before a PRP draw.
A systematic review of post-procedure protocols for tendinopathy found that stretching programs generally began two to seven days after injection, strengthening programs started within two to three weeks, and return to full activity or sport was most commonly scheduled at four to six weeks. Only about 20 percent of studies restricted NSAIDs before the injection, but 56 percent restricted them afterward, typically for more than two weeks.26PubMed. Post-Procedure Protocols Following Platelet-Rich Plasma Injections for Tendinopathy: A Systematic Review For knee osteoarthritis, the pattern was similar: about 55 percent of reviewed trials mentioned post-injection NSAID restriction, with the most common window being longer than four weeks, and about a third mentioned weight-bearing restrictions.27Journal of Cartilage & Joint Preservation. Postinjection protocols following platelet rich plasma injection for knee osteoarthritis: a systematic review of randomized controlled trials
Safety and Side Effects
Because PRP is made from your own blood, the risk of allergic reaction or disease transmission is essentially zero. The real-world side effect profile reflects mechanical and inflammatory responses rather than immune rejection. A meta-analysis of intra-articular PRP for knee osteoarthritis found that adverse events were reported in about 19 percent of cases, with mild knee pain and swelling being the most common at roughly 11 percent. Leukocyte-rich PRP had significantly higher rates of that mild pain and swelling compared to hyaluronic acid, while leukocyte-poor PRP did not. No severe adverse events were reported in any group.28PubMed Central. Assessment of adverse events and safety associated with intra-articular platelet-rich plasma injections compared to other injectates for knee osteoarthritis
A broader literature survey flagged postoperative infections as the most commonly reported serious adverse event across all PRP applications, along with rarer complications like localized inflammation, nodule formation, and in very rare cases involving facial injections, blindness from inadvertent vascular occlusion.29PubMed Central. Adverse events related to platelet-rich plasma therapy and future issues to be resolved The infection risk is the strongest argument for standardizing preparation protocols under good manufacturing practice conditions.
The Cost Question
PRP injections are rarely covered by insurance for orthopedic indications in the United States, with a single injection often costing several hundred dollars out of pocket. Whether that expense pays off depends on the condition being treated and the alternative. A cost-effectiveness model for knee osteoarthritis found that from a healthcare-payer perspective, proceeding directly to total knee replacement actually produced slightly more quality-adjusted life years at slightly lower total cost than using PRP to delay surgery, assuming PRP’s published cost of about $728 per injection. PRP became cost-effective only if it improved quality of life above a specific threshold or if the delay to surgery exceeded ten years.30Journal of Bone and Joint Surgery. The Cost-Effectiveness of Platelet-Rich Plasma Injections for Knee Osteoarthritis
The picture looks different in other conditions. For diabetic foot ulcers, a cost-effectiveness analysis found PRP gel to be cost-saving over both one-year and five-year time horizons compared to standard wound care alone.31PubMed Central. Cost-Effectiveness Analysis for Managing Diabetic Foot Ulcer (DFU) in USA: Platelet-Rich Plasma (PRP) vs Standard of Care (SoC) For carpal tunnel syndrome, a separate Markov model found PRP injections more cost-effective than corticosteroid injections from both healthcare and societal perspectives.32PubMed Central. Platelet-Rich Plasma Versus Corticosteroid Injections for the Treatment of Mild-to-Moderate Carpal Tunnel Syndrome The lesson is that PRP’s economic value is highly condition-specific: it may be a poor value proposition when the alternative is a highly effective surgery, but a clear winner when it replaces repeated wound care visits or steroid shots with diminishing returns.
PRP in Veterinary Medicine
Horses were actually among the earliest recipients of PRP therapy, largely because tendon and ligament injuries are common and career-ending in athletic horses, and owners are motivated to try regenerative options. A systematic review of PRP for equine tendon and ligament injuries found a favorable safety profile with no severe adverse effects, along with improvements in lameness scores, tissue organization on ultrasound, and return-to-work rates. The same formulation inconsistencies that plague human studies showed up in veterinary research: variability in whether preparations were leukocyte-rich or leukocyte-reduced, what activation method was used, and how outcomes were measured. Only about 27 percent of studies scored well on PRP reporting quality.33PubMed Central. Efficacy of Platelet-Rich Plasma in the Treatment of Equine Tendon and Ligament Injuries The parallel with human medicine is striking: PRP appears to help, but sloppy reporting makes it hard to say which protocol works best.
Platelet-Rich Fibrin and Newer Variants
PRP is not the only platelet concentrate in use. Platelet-rich fibrin (PRF) is made by spinning blood without an anticoagulant, so the sample begins clotting during centrifugation and produces a fibrin membrane that can be handled and placed directly into a surgical site. Variants like advanced PRF (A-PRF), titanium PRF (T-PRF), and commercial platelet-rich fibrin matrix (PRFM) products differ in their centrifuge settings and, in some cases, the material of the collection tube.
A comparison of the mechanical properties of several PRF variants found that PRFM products performed significantly better than standard PRF forms in storage modulus, loss modulus, and elasticity measures, while A-PRF and PRFM products showed higher hardness.34Biomaterials Investigating in Dentistry / PubMed Central. Comparative evaluation of mechanical properties of leukocyte rich platelet rich fibrin, advanced-platelet rich fibrin, titanium-platelet rich fibrin, selphyl platelet rich fibrin matrix and merisis platelet rich fibrin matrix These differences matter mostly in surgical contexts where the membrane needs to hold its shape, such as oral surgery, bone grafting, or wound coverage. For injectable applications like joint or tendon treatment, liquid PRP remains the standard.
The regulatory landscape adds another layer of complexity. In Europe, the level of blood manipulation required for PRP preparation increasingly triggers good manufacturing practice requirements, pushing production toward hospital-based blood banks rather than bedside centrifuges. The intent is to standardize what has historically been a clinic-by-clinic operation, enabling cleaner comparison across studies and more consistent results for patients. Whether that level of regulation helps or simply adds cost and complexity is an open question the field is still working through.